Home009420 • KRX
add
Hanall Biopharma Co Ltd
Previous close
₩26,600.00
Day range
₩26,100.00 - ₩27,650.00
Year range
₩24,200.00 - ₩52,000.00
Market cap
1.43T KRW
Avg Volume
455.29K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 36.42B | 14.82% |
Operating expense | 16.25B | -14.85% |
Net income | 1.62B | 156.59% |
Net profit margin | 4.45 | 149.28% |
Earnings per share | — | — |
EBITDA | 3.65B | 202.54% |
Effective tax rate | 32.65% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 24.71B | -56.27% |
Total assets | 212.88B | -11.21% |
Total liabilities | 44.53B | -16.81% |
Total equity | 168.35B | — |
Shares outstanding | 50.77M | — |
Price to book | 8.02 | — |
Return on assets | 3.22% | — |
Return on capital | 4.00% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | 1.62B | 156.59% |
Cash from operations | 3.53B | 17.50% |
Cash from investing | -7.51B | -274.69% |
Cash from financing | 1.37B | 655.30% |
Net change in cash | -2.55B | -3,069.26% |
Free cash flow | -569.72M | 81.57% |
About
Founded
1973
Headquarters
Website
Employees
309
